NCT06602869Recruiting
Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis
Cellular Markers During a Non-tuberculous Mycobacterial Respiratory Infection, Treated or Untreated, in Patients With Cystic Fibrosis
Source: ClinicalTrials.gov · Last updated 10 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study evaluates a diagnostic serological test for Non-Tuberculous Mycobacteria (NTM) infection in cystic fibrosis patients by measuring T cell response. It aims to highlight a dynamic response associated to the pathogen's presence. This multicenter case-control study involves two populations, providing a better understanding of the circulating T-IFNγ-MNT response in these patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 76 (estimated)
- First submitted
- 16 Sept 2024
- Start date
- 17 Sept 2024
- Primary completion date
- 1 Aug 2026
- Lead sponsor
- University Hospital, Montpellier
- Diseases
- Cystic fibrosis
- NCT number
- NCT06602869
What you commit to
- Study type: Observational
- Planned participants: 76
- From 17 Sept 2024 to the primary completion date, 1 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Lung transplant patients
Other
- Person placed under judicial protection
- Pregnant and breastfeeding women
Who the study is looking for
- Patient ≥18 years
- Patient previously included in the CIMeNT study
- Patient with a confirmed diagnosis of cystic fibrosis regardless of CFTR genotype
- Patient affiliated to the social security system
- Patient registered in the French Cystic Fibrosis Registry
- Adult patient capable of spontaneous expectoration or after induction
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Montpellier - Hôpital Arnaud de Villeneuve Coordinator of this site? Confirm its status | Montpellier | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.